Telehealth approach for amyotrophic lateral sclerosis patients : the experience during COVID-19 pandemic
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd..
BACKGROUND AND OBJECTIVE: Specialized multidisciplinary ALS care has been shown to extend survival and improve patient's and caregiver's quality of life. During the COVID-19 pandemic, the management of patients suddenly changed and telemedicine has been proven to be as effective as outpatient care. We elaborate the experience with Telemedicine of a Tertiary ALS Center from an Italian geographical area with high infectious risk during the COVID-19 pandemic.
METHODS: 19 patients were evaluated in telemedicine by a multidisciplinary team including a neurologist (clinical evaluation, intercurrent events, and drug prescriptions); a dietician (diet and weight monitoring); a psychologist (psychological assessment and support); and a physiotherapist (physiotherapy treatment and device prescription). Telemedicine was performed using the online platform "IoMT Connected Care Platform (Ticuro Reply).".
RESULTS: All patients reported a positive perception of talking face to face with healthcare professionals and were satisfied with how the team understood their problems. During video televisits, there was a change in the patient's medication regimen in 11/19; 2/19 required pneumological evaluation and started NIV; and 9/16 patients required prescription of devices. The mean monthly decline of ALSFRS-R before televisit was 0.88 (SD 1.17) and during televisit of 0.49 (SD 0.75). Bodyweight and daily caloric content remain stable. Reduction in HADS scores and stability in ALSAQ-40 were observed.
DISCUSSION: Our study positively reproduced the multidisciplinary approach currently used with ALS patients, trying to stabilize the functional and metabolic status and improving the psychological one. Future directions include a personalized telemedicine program according to the patient's needs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:143 |
|---|---|
| Enthalten in: |
Acta neurologica Scandinavica - 143(2021), 5 vom: 13. Mai, Seite 489-496 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
De Marchi, Fabiola [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Amyotrophic lateral sclerosis |
|---|
| Anmerkungen: |
Date Completed 12.04.2021 Date Revised 12.04.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/ane.13373 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317533738 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317533738 | ||
| 003 | DE-627 | ||
| 005 | 20231225163451.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/ane.13373 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1058.xml |
| 035 | |a (DE-627)NLM317533738 | ||
| 035 | |a (NLM)33185886 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a De Marchi, Fabiola |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Telehealth approach for amyotrophic lateral sclerosis patients |b the experience during COVID-19 pandemic |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.04.2021 | ||
| 500 | |a Date Revised 12.04.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. | ||
| 520 | |a BACKGROUND AND OBJECTIVE: Specialized multidisciplinary ALS care has been shown to extend survival and improve patient's and caregiver's quality of life. During the COVID-19 pandemic, the management of patients suddenly changed and telemedicine has been proven to be as effective as outpatient care. We elaborate the experience with Telemedicine of a Tertiary ALS Center from an Italian geographical area with high infectious risk during the COVID-19 pandemic | ||
| 520 | |a METHODS: 19 patients were evaluated in telemedicine by a multidisciplinary team including a neurologist (clinical evaluation, intercurrent events, and drug prescriptions); a dietician (diet and weight monitoring); a psychologist (psychological assessment and support); and a physiotherapist (physiotherapy treatment and device prescription). Telemedicine was performed using the online platform "IoMT Connected Care Platform (Ticuro Reply)." | ||
| 520 | |a RESULTS: All patients reported a positive perception of talking face to face with healthcare professionals and were satisfied with how the team understood their problems. During video televisits, there was a change in the patient's medication regimen in 11/19; 2/19 required pneumological evaluation and started NIV; and 9/16 patients required prescription of devices. The mean monthly decline of ALSFRS-R before televisit was 0.88 (SD 1.17) and during televisit of 0.49 (SD 0.75). Bodyweight and daily caloric content remain stable. Reduction in HADS scores and stability in ALSAQ-40 were observed | ||
| 520 | |a DISCUSSION: Our study positively reproduced the multidisciplinary approach currently used with ALS patients, trying to stabilize the functional and metabolic status and improving the psychological one. Future directions include a personalized telemedicine program according to the patient's needs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a amyotrophic lateral sclerosis | |
| 650 | 4 | |a multidisciplinary care | |
| 650 | 4 | |a telemedicine | |
| 700 | 1 | |a Sarnelli, Maria Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Serioli, Marcella |e verfasserin |4 aut | |
| 700 | 1 | |a De Marchi, Ilaria |e verfasserin |4 aut | |
| 700 | 1 | |a Zani, Ermes |e verfasserin |4 aut | |
| 700 | 1 | |a Bottone, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Ambrosini, Serena |e verfasserin |4 aut | |
| 700 | 1 | |a Garone, Raffaella |e verfasserin |4 aut | |
| 700 | 1 | |a Cantello, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Mazzini, Letizia |e verfasserin |4 aut | |
| 700 | 0 | |a CANPALS Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Solara, Valentina |e investigator |4 oth | |
| 700 | 1 | |a Biroli, Giampaolo |e investigator |4 oth | |
| 700 | 1 | |a Riso, Sergio |e investigator |4 oth | |
| 700 | 1 | |a Vercelli, Renato |e investigator |4 oth | |
| 700 | 1 | |a Massara, Maurilio |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Acta neurologica Scandinavica |d 1961 |g 143(2021), 5 vom: 13. Mai, Seite 489-496 |w (DE-627)NLM000056022 |x 1600-0404 |7 nnns |
| 773 | 1 | 8 | |g volume:143 |g year:2021 |g number:5 |g day:13 |g month:05 |g pages:489-496 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/ane.13373 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 143 |j 2021 |e 5 |b 13 |c 05 |h 489-496 | ||